AI Miners Surge Pre-Market on Record $38B Oracle Data Center Deal Boosts Sector
Artificial Intelligence (AI) and High Performance Computer (HPC) mining stocks are rallying pre-market following news of the largest AI infrastructure financing on record, according to Bloomberg.
Cipher Mining (CIFR) and IREN (IREN) are both up 7%, while Bitfarms (BITF) has jumped 12%, as investors rotate back into AI-exposed assets after a recent correction. The rebound comes as banks prepare a $38 billion debt sale to fund two major data centers tied to Oracle Corp (ORCL), in what would be the biggest financing ever for AI infrastructure.
The debt is split into two senior secured credit facilities: $23.25 billion for a Texas project and $14.75 billion for a Wisconsin site, both being developed by Vantage Data Centers for Oracle’s partnership with OpenAI under the Stargate initiative.
The loans will mature in four years, with two one-year extension options, and are expected to price about 2.5% points above the benchmark, according to the article.
Oracle’s broader plan includes up to $500 billion in AI infrastructure investment, underscoring its ambitions in cloud computing and artificial intelligence.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI Credit Pressure Surfaces: CoreWeave Bonds Become the New Barometer for the US Stock Market
CoreWeave's unsecured bonds have replaced Nvidia as the market's "beta barometer" for measuring AI trades. The bonds’ yields have surged past 16% and CDS spreads have soared, highlighting the high dependence of emerging cloud computing companies on debt financing and their funding gap risks. Credit pressures are spreading from infrastructure to equity markets, and the main focus of AI trading has shifted from computing power demand to financing costs and sustainability.
GSK (GSK.US), Inovio (INO.US), and Agios (AGIO.US) cluster for review, US innovative drugs welcome FDA approval window
The FDA will intensively decide on several new drugs in the next two weeks: GSK's functional cure therapy for hepatitis B, Inovio's rare disease therapy, Agios's new drug for sickle cell disease, and Sun Pharma's application for expanded indications.
After the Philadelphia Semiconductor Index and Nasdaq plunged, Morgan Stanley called to "get ready to increase positions"
Michael Wilson from Morgan Stanley stated that as the significant correction trajectory in most stock markets over the past few months is about to end, investors should be prepared to increase the risk exposure in their portfolios.
Roadster is just an appetizer? Renowned investor predicts: SpaceX (SPCX.US) may announce the acquisition of Tesla (TSLA.US) within weeks at $420 per share
Gary Black, Managing Director of the Future Fund, recently tweeted a prediction that SpaceX may announce an all-stock acquisition of Tesla within weeks and view the launch of the flying edition Roadster as an opportunity to integrate Elon Musk's companies.
Crypto prices
More
